Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Radioiodine Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06860971
What this trial is testing

AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma

Who this might be right for
Thyroid Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 144
Not applicableUnknownNCT02114619
What this trial is testing

Comparative Study of Different I-131 Doses in Graves' Disease

Who this might be right for
Graves' Disease
Mashhad University of Medical Sciences 450
Testing effectiveness (Phase 2)Active Not RecruitingNCT04061980
What this trial is testing

Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer

Who this might be right for
BRAF NP_004324.2:p.V600MBRAF V600E Mutation PresentMetastatic Thyroid Gland Carcinoma+4 more
Providence Health & Services 24
Post-approval studies (Phase 4)Study completedNCT00150124
What this trial is testing

Block-replacement Therapy During Radioiodine Therapy

Who this might be right for
Toxic Nodular GoitreGraves' Disease
Steen Bonnema 100
Not applicableStudy completedNCT02375451
What this trial is testing

Effect of Childhood Radioiodine Therapy on Salivary Function

Who this might be right for
XerostomiaHyperthyroidismThyroid Cancer
Boston Children's Hospital 70
Testing effectiveness (Phase 2)Study completedNCT00085293
What this trial is testing

Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131

Who this might be right for
Recurrent Thyroid CancerStage IVA Follicular Thyroid CancerStage IVA Papillary Thyroid Cancer+4 more
National Cancer Institute (NCI) 12
Not applicableStudy completedNCT00148213
What this trial is testing

Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma

Who this might be right for
Thyroid Neoplasms
University Hospital Muenster 100
Not applicableUnknownNCT04354324
What this trial is testing

Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma

Who this might be right for
Papillary Thyroid Cancer
Zhujiang Hospital 254
Large-scale testing (Phase 3)Study completedNCT01876784
What this trial is testing

Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer
Genzyme, a Sanofi Company 238
Not applicableStudy completedNCT03363347
What this trial is testing

BRAF V600E and Redifferentiation Therapy in Radioiodine-refractory Papillary Thyroid Cancer

Who this might be right for
Thyroid Cancer
Heidelberg University 25
Testing effectiveness (Phase 2)Study completedNCT00454220
What this trial is testing

Study to Determine the Dose, the Safety and Effectiveness of a New Drug, Modified Release rhTSH, in Patients With Multinodular Goiter

Who this might be right for
Multinodular Goiter
Genzyme, a Sanofi Company 96
Not applicableStudy completedNCT03397238
What this trial is testing

Myeloid Cell Reprogramming in Thyroid Carcinoma

Who this might be right for
Thyroid Cancer
Radboud University Medical Center 41
Testing effectiveness (Phase 2)Study completedNCT01813136
What this trial is testing

Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma

Who this might be right for
Thyroid Carcinoma
Centre Leon Berard 168
Not applicableLooking for participantsNCT05994365
What this trial is testing

Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma

Who this might be right for
Thyroid Neoplasms
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 380
Post-approval studies (Phase 4)Study completedNCT00150137
What this trial is testing

Antithyroid Drugs During Radioiodine Therapy

Who this might be right for
Toxic Nodular GoitreGraves Disease
Odense University Hospital 80
Not applicableStudy completedNCT04876287
What this trial is testing

Salivary dysfuncTion After Radioiodine Treatment

Who this might be right for
Thyroid Cancer
French Nuclear Safety and Radiation Protection Authority (ASNR) 138
Not applicableStudy completedNCT00509483
What this trial is testing

Three-Year Follow-up of Radioiodine Therapy for Goitre

Who this might be right for
Tratment of Multinodular Goitre
University of Sao Paulo 40
Very early researchLooking for participantsNCT06898437
What this trial is testing

Study of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid Cancer

Who this might be right for
Radioiodine Refractory Differentiated Thyroid Cancer
Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT04327999
What this trial is testing

Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System

Who this might be right for
Thyroid CarcinomaRadioactive Iodine Level
Vanderbilt-Ingram Cancer Center 9
Testing effectiveness (Phase 2)Study completedNCT00026533
What this trial is testing

Thalidomide in Treating Patients With Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Kenneth Ain
Next Page